The complicated and disturbing case of Dan Markingson, the mentally ill young man from St. Paul who committed suicide in 2004 while enrolled in a University of Minnesota clinical trial of the antipsychotic drug Seroquel, has become embroiled in even more controversy in recent weeks.
MinnPost